Skip to main content
Caplight Logo









GeneNeer

GeneNeer

Private
ShohamHealthcare & Life Scienceshttps://geneneer.com/

Last Round

Seed

Jan 9, 2024

Total Funding Raised

$2.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

GeneNeer is an agritech company that develops gene-editing platforms for smart and fast crop breeding to address the impacts of climate change.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

gene editingagritechcrop breedingbiotechnologyCRISPRplant resilienceseed developmentag-biotechtissue culturetrait developmentbioinformaticsgenomic innovationGMO alternativesprecision agriculturesynthetic biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GeneNeer Comparables

Compare GeneNeer with similar companies based on industry and business-model similarity.

GeneNeer comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hudson River Biotechnology
84%
Phytoform Labs
84%
Spearhead Bio
79%

GeneNeer Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 9, 2024

Key People

Founding team and executive leadership

Kinneret Shefer

Chief Executive Officer Cofounder

Founding Team

GeneNeer Investors

Notable investors and investment history

GeneNeer investors
InvestorRounds
Tall Grass VenturesSeed
2b AHEAD VenturesPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 3092% MoM, reaching 3.1K.

  • May 14, 2025

    Gusui Wu joins as Senior Scientific Advisor.

GeneNeer Filings

Explore SEC and related filing metadata, where available.

GeneNeer filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GeneNeer's valuation, stock price, and market status.

Is GeneNeer a public or private company?

GeneNeer is a private company.

What is the current stock price of GeneNeer?

GeneNeer is a private company with no public stock price. No recent secondary market data is available.

How much is GeneNeer worth (valuation)?

Valuation information for GeneNeer is not publicly available.

Can I buy GeneNeer stock?

GeneNeer shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GeneNeer's last funding round?

GeneNeer's most recent funding round was Seed on January 9, 2024.

Who are the main investors in GeneNeer?

Key investors in GeneNeer include Tall Grass Ventures, 2b AHEAD Ventures.

Will GeneNeer IPO soon?

No public IPO plans have been announced for GeneNeer.

How can I track GeneNeer secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GeneNeer's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShoham
Employee Range10
Year Founded2016
Last FundingJan 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?